home / stock / igx:cc / igx:cc news

IGX:CC News and Press, Intelgenx Technologies Corp. From 11/03/22

Stock Information
Company Name: Intelgenx Technologies Corp.
Stock Symbol: IGX:CC
Market: TSXC
Website: intelgenx.com
Menu
IGX:CC IGX:CC Quote IGX:CC Short IGX:CC News IGX:CC Articles IGX:CC Message Board
Get IGX:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
IGX:CC - IntelGenx to Report Third Quarter 2022 Financial Results on November 10, 2022 - Conference Call to Follow

SAINT LAURENT, Quebec, Nov. 03, 2022 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical films, today announced that it will release its third quarter 2022 financial results after market close on Thursday, November ...
IGX:CC - IntelGenx Files Provisional U.S. Patent Application for Advanced Oral Film Formulation Improving Cannabinoid Onset of Action

SAINT LAURENT, Quebec, Nov. 02, 2022 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx”), a leader in pharmaceutical films, today announced it has filed a new provisional patent application with the United States Patent and Trademark Office ...

IGX:CC - IntelGenx Receives FDA GDUFA Date for Xiromed-Partnered Development Candidate, Buprenorphine Buccal Film

SAINT LAURENT, Quebec, Oct. 25, 2022 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx") today announced that its previously undisclosed development candidate, Buprenorphine Buccal Film, for which an abbreviated new drug application (“ANDA&#...

IGX:CC - IntelGenx Announces Issuance of New U.S. Patent Covering VersaFilm® Technology

SAINT LAURENT, Quebec, Oct. 20, 2022 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx"), a leader in pharmaceutical films, today announced that the United States Patent and Trademark Office (USPTO) issued U.S. Patent No. 11,471,406 to IntelGe...
IGX:CC - IntelGenx Submits Response to CRL from FDA for RIZAPORT® VersaFilm®

SAINT LAURENT, Quebec, Oct. 18, 2022 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx"), a leader in pharmaceutical films, today announced that it has responded to the Complete Response Letter (“CRL”) for its 505(b)(2) New Drug Appli...

IGX:CC - IntelGenx's Collaboration with atai Life Sciences Culminates in the Initiation of First-in-Human Clinical Study of an Oral Thin Film Psychedelic Drug Candidate

SAINT LAURENT, Quebec, Oct. 13, 2022 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx") today provided an update on its collaboration with its strategic partner, atai Life Sciences (NASDAQ:ATAI) (“atai”), for the development of novel...

IGX:CC - IntelGenx Announces Enrollment Reaches Halfway Mark in 'BUENA' Montelukast VersaFilm® Phase 2a Clinical Trial in Patients with Mild to Moderate Alzheimer's Disease

SAINT LAURENT, Quebec, Sept. 08, 2022 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx") today announced that patient enrollment in the ongoing Montelukast VersaFilm ® Phase 2a (“BUENA”) clinical trial in patients with mild ...
IGX:CC - IntelGenx Reports Second Quarter 2022 Financial Results

SAINT LAURENT, Quebec, Aug. 11, 2022 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx") today reported financial results for the second quarter ended June 30, 2022. All dollar amounts are expressed in U.S. currency, unless otherw...

IGX:CC - IntelGenx to Report Second Quarter 2022 Financial Results on August 11, 2022 - Conference Call to Follow

SAINT LAURENT, Quebec, Aug. 04, 2022 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical films, today announced that it will release its second quarter 2022 financial results after market close on Thursday, August 1...

IGX:CC - IntelGenx Announces Completion of Share Issuance in Payment of Principal and Interest on Debentures

SAINT LAURENT, Quebec, July 05, 2022 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (the “ Company ” or “ IntelGenx ”) announces that, as previously disclosed on June 1, 2022 and in accordance with the terms of the trust inde...
Previous 10 Next 10